Armando Tellez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Armando Tellez has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Juan F. Granada
Cardiovascular Research Foundation
9 shared publications - Geng-Hua Yi
CRF, Orangeburg, New York, USA
6 shared publications Yanping Cheng
Skirball Center for Cardiovascular Research Cardiovascular Research Foundation Orangeburg New York
6 shared publications- Krzysztof Milewski
American Heart of Poland, ul. Armii Krajowej 101, 43-316 Bielsko-Biała, Poland
5 shared publications Greg L. Kaluza
Skirball Center for Cardiovascular Research Cardiovascular Research Foundation Orangeburg New York
4 shared publicationsGreg Kaluza
Cardiovascular Research Foundation, Orangeburg, NY
3 shared publications
Latest Publications
- 18 September 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (5) , 914-922
Nanospheres encapsulated everolimus delivery into arterial wall–the tissue pharmacokinetics and vascular response experimental study
Objective: This study aimed to evaluate the pharmacokinetic profile and tissue effects of everolimus delivered into arterial wall using biodegradable nanospheres.Background: Delivery of everolimus into the arterial wall is challenging due to its low‐lipophilic profile.Methods: A pharmacokinetic study included 28 porcine coronary arterial segments initially injured with balloon angioplasty followed by the local delivery of everolimus encapsulated in nanospheres (EEN) via injection through a microporous delivery catheter. The animals were sacrificed at 1 hour, 1,7,28, and 90‐day follow‐up. In the tissue effects study 16 coronary bare metal stent (BMS) were implanted following EEN delivery, 15 BMS following nanospheres delivery without the drug (reference group) and 16 implanted BMS served as a control. Angiographic and histology follow‐up was scheduled at 28 and 90‐day.Results: The study showed high‐everolimus concentrations in arterial tissue early after nanoparticles delivery followed by its gradual decrease to 1.15 ± 0.40 ng/mg at 90 days. Histology analysis showed favorable biocompatibility and healing profile with comparable area stenosis between groups at both time‐points.Conclusions: The present study demonstrates for the first time the safety, biocompatibility, and long‐term retention of everolimus in arterial tissue after single local delivery of biodegradable nanospheres.
- 18 September 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (5) , 914-922
Nanospheres encapsulated everolimus delivery into arterial wall–the tissue pharmacokinetics and vascular response experimental study
Objective: This study aimed to evaluate the pharmacokinetic profile and tissue effects of everolimus delivered into arterial wall using biodegradable nanospheres.Background: Delivery of everolimus into the arterial wall is challenging due to its low‐lipophilic profile.Methods: A pharmacokinetic study included 28 porcine coronary arterial segments initially injured with balloon angioplasty followed by the local delivery of everolimus encapsulated in nanospheres (EEN) via injection through a microporous delivery catheter. The animals were sacrificed at 1 hour, 1,7,28, and 90‐day follow‐up. In the tissue effects study 16 coronary bare metal stent (BMS) were implanted following EEN delivery, 15 BMS following nanospheres delivery without the drug (reference group) and 16 implanted BMS served as a control. Angiographic and histology follow‐up was scheduled at 28 and 90‐day.Results: The study showed high‐everolimus concentrations in arterial tissue early after nanoparticles delivery followed by its gradual decrease to 1.15 ± 0.40 ng/mg at 90 days. Histology analysis showed favorable biocompatibility and healing profile with comparable area stenosis between groups at both time‐points.Conclusions: The present study demonstrates for the first time the safety, biocompatibility, and long‐term retention of everolimus in arterial tissue after single local delivery of biodegradable nanospheres.
- 1 October 2014
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 10 (6) , 724-731
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 October 2014
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 10 (6) , 724-731
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 29 October 2013
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 83 (3) , 397-404
Long‐term impact of balloon postdilatation on neointimal formation: An experimental comparative study between second‐generation self‐expanding versus balloon‐expandable stent technologies
Background Self‐expanding stents (SES) are reemerging as therapeutic alternatives to treat coronary artery disease. It has been proposed that SES can improve clinical outcomes by inducing less injury at implantation and achieving better vessel wall apposition. To date, little data exists comparing the vascular response to both methods of deployment in a controlled experimental setting. Objective To quantify differences in vascular injury and healing between second‐generation SES and balloon‐expandable stents (BES) and the effects of balloon postdilatation in a porcine coronary model. Methods Seventy‐five bare SES (AXXESS or vProtect) and 42 BES (Vision) were implanted in porcine coronaries. A subset of these received balloon postdilatation (SES + D = 22, BES + D = 20). Follow‐up was scheduled at 30 (BES = 10, BES + D = 6, SES = 19, SES + D = 8), 90 (BES = 6, BES + D = 8, SES = 19, SES + D = 8), and 180 days (BES = 6, BES + D = 6, SES = 15, SES + D = 6). Results In vivo imaging and histological analysis showed that neointimal formation peaks early (30 days) in BES. Conversely, for SES, the peak occurred later (90 days). However, the neointimal formation achieved in either group equalized at 180 days. For SES, postdilatation shortened the peak of neointimal formation to 30 days. Conversely, for BES, postdilatation delayed the peak of neointimal formation to 90 days. At 30 days, histology showed that SES had significantly less injury. However, at 90 days, injury scores tended to be higher for SES. By 180 days, injury scores were comparable between both groups. Conclusions The mechanism of stent expansion influences the degree of vascular injury and healing. The synergistic use of balloon postdilatation changes the dynamics of healing and may impact the potential beneficial effects inherent to SES technologies.
- 29 October 2013
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 83 (3) , 397-404
Long‐term impact of balloon postdilatation on neointimal formation: An experimental comparative study between second‐generation self‐expanding versus balloon‐expandable stent technologies
Background Self‐expanding stents (SES) are reemerging as therapeutic alternatives to treat coronary artery disease. It has been proposed that SES can improve clinical outcomes by inducing less injury at implantation and achieving better vessel wall apposition. To date, little data exists comparing the vascular response to both methods of deployment in a controlled experimental setting. Objective To quantify differences in vascular injury and healing between second‐generation SES and balloon‐expandable stents (BES) and the effects of balloon postdilatation in a porcine coronary model. Methods Seventy‐five bare SES (AXXESS or vProtect) and 42 BES (Vision) were implanted in porcine coronaries. A subset of these received balloon postdilatation (SES + D = 22, BES + D = 20). Follow‐up was scheduled at 30 (BES = 10, BES + D = 6, SES = 19, SES + D = 8), 90 (BES = 6, BES + D = 8, SES = 19, SES + D = 8), and 180 days (BES = 6, BES + D = 6, SES = 15, SES + D = 6). Results In vivo imaging and histological analysis showed that neointimal formation peaks early (30 days) in BES. Conversely, for SES, the peak occurred later (90 days). However, the neointimal formation achieved in either group equalized at 180 days. For SES, postdilatation shortened the peak of neointimal formation to 30 days. Conversely, for BES, postdilatation delayed the peak of neointimal formation to 90 days. At 30 days, histology showed that SES had significantly less injury. However, at 90 days, injury scores tended to be higher for SES. By 180 days, injury scores were comparable between both groups. Conclusions The mechanism of stent expansion influences the degree of vascular injury and healing. The synergistic use of balloon postdilatation changes the dynamics of healing and may impact the potential beneficial effects inherent to SES technologies.
- Open Access
- 1 June 2011
- Published by American Physiological Society in Physiological Genomics
- Vol. 43 (12) , 781-788
Gene expression differences in healthy brachial and femoral arteries of Rapacz familial hypercholesterolemic swine
The mechanisms underlying the unequal distribution of atherosclerotic disease in the peripheral arteries are currently unclear. Gene expression differences in healthy arteries may influence the heterogeneous distribution of atherosclerosis. Therefore, this investigation compares gene expression in healthy atheroprotected brachial and atherosusceptible femoral arteries of young and disease free Rapacz familial hypercholesterolemic (FHC) swine. We hypothesized that transcripts related to atherosusceptibility would be differentially expressed between these arteries prior to the onset of disease. Femoral and brachial arteries were harvested from four 13-day-old Rapacz FHC swine. No atherosclerotic disease was detected using Sudan IV, Verhoeff-van Gieson, and hematoxylin-eosin staining. Gene expression was quantified using Affymetrix GeneChip Porcine Genome Arrays. An average of 15,552 probe sets had detectable transcripts, while 430 probe sets showed a significant differential expression between arteries (false discovery rate < 0.05). The human orthologs of 63 probe sets with differential expression and a 1.5-fold or greater transcript abundance between arteries are associated with Wnt/β-catenin, lysophospholipid, and Ca-signaling, as well as apoptosis. This is the first investigation reporting that differences in relative abundance of gene expression exist between brachial and femoral arteries in young Rapacz FHC swine prior to the development of atherosclerotic lesions.
- 1 June 2011
- Published by American Physiological Society in Physiological Genomics
- Vol. 43 (12) , 781-788
Open AccessGene expression differences in healthy brachial and femoral arteries of Rapacz familial hypercholesterolemic swine
The mechanisms underlying the unequal distribution of atherosclerotic disease in the peripheral arteries are currently unclear. Gene expression differences in healthy arteries may influence the heterogeneous distribution of atherosclerosis. Therefore, this investigation compares gene expression in healthy atheroprotected brachial and atherosusceptible femoral arteries of young and disease free Rapacz familial hypercholesterolemic (FHC) swine. We hypothesized that transcripts related to atherosusceptibility would be differentially expressed between these arteries prior to the onset of disease. Femoral and brachial arteries were harvested from four 13-day-old Rapacz FHC swine. No atherosclerotic disease was detected using Sudan IV, Verhoeff-van Gieson, and hematoxylin-eosin staining. Gene expression was quantified using Affymetrix GeneChip Porcine Genome Arrays. An average of 15,552 probe sets had detectable transcripts, while 430 probe sets showed a significant differential expression between arteries (false discovery rate < 0.05). The human orthologs of 63 probe sets with differential expression and a 1.5-fold or greater transcript abundance between arteries are associated with Wnt/β-catenin, lysophospholipid, and Ca-signaling, as well as apoptosis. This is the first investigation reporting that differences in relative abundance of gene expression exist between brachial and femoral arteries in young Rapacz FHC swine prior to the development of atherosclerotic lesions.
- 1 January 2010
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 5 (6) , 731-736
In vivo intravascular ultrasound analysis of the absorption rate of the Angio-Seal™ vascular closure device in the porcine femoral artery
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 January 2010
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 5 (6) , 731-736
In vivo intravascular ultrasound analysis of the absorption rate of the Angio-Seal™ vascular closure device in the porcine femoral artery
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 October 2007
- Published by Elsevier in American Heart Journal
- Vol. 154 (4) , 694.e1-694.e7
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease
- 1 October 2007
- Published by Elsevier in American Heart Journal
- Vol. 154 (4) , 694.e1-694.e7
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease